Previous Close | 28.75 |
Open | 28.58 |
Bid | 28.03 x 1100 |
Ask | 29.42 x 1000 |
Day's Range | 27.48 - 28.79 |
52 Week Range | 22.01 - 33.71 |
Volume | |
Avg. Volume | 1,879,391 |
Market Cap | 4.6B |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | 9.00 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ALKS
Alkermes PLC (NASDAQ:ALKS), a global biopharmaceutical company, is focused on developing innovative medicines that address unmet needs in the fields of neuroscience and oncology.
In the most recent trading session, Alkermes (ALKS) closed at $28.75, indicating a -0.45% shift from the previous trading day.
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.